I believe that too many investors believe that corporate
I believe that too many investors believe that corporate management's job is to prop up the share price on a daily basis. Clearly it isn't. Corporate management is working to build long term growth in the company, and if it continues doing that, in time the day to day price will take care of itself.
Where I believe our management needs to improve is in communicating with investors in clearly understandable language.
It's my belief that when the corporation stated that certain products are "Market Ready" investors understand it as meaning they're ready to market the product. On the other hand, the company's meaning may be that they now have commercial manufacturing capability that meets the requirements of authorities such as the FDA for commercial sales. If this were a traditional biotech, this would be a major step as such manufacturing capability often requires a major investment. OWCP with it's alliance with Emilia has established a source for commercial product, so they've accomplished this step with no up front cost.
I'm not saying this is the case, I'm saying they are not communicating clearly, and that we as investors have taken market ready as meaning it could be marketed virtually any day. Perhaps this too is correct, but only if they wanted to market the product as a cosmetic or nutraceutical with no real proof of efficacy. Again, many believed that this is what they were planning to do, in spite of the fact the company never said so.
Personally I hope they intend to do something that's in between full government approval and no real proof whatsoever. Something roughly the equal of a small Phase 2 trial should demonstrate efficacy, but isn't close to the amount of data required by the FDA or other governments agencies to grant full approval. Yes, they could market as a cosmetic or nutraceutical, but they would have trials based data that demonstrated the benefits of the products. This is what I believe they could achieve with the trials which Mediq described, which could be done in 3 to 6 months.
Gary
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...
Continue Reading
Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...
Continue Reading
Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...
Continue Reading
Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...
Continue Reading
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...
Continue Reading
Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...
Continue Reading
Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
Top 5 Most Recently Viewed Articles
A Fresh Perspective on Auto Loan Preapproval Diving into the maze of auto financing, sometimes you gotta stop and smell the coffee—that's where this HelloNation piece comes in, serving a dose of clarity for potential car buyers. Brad Bailey, the top dog at Red River Credit Union, steps into the fray to break it down. Gaining Financial Insight Ahead of the Game Think of...
Continue Reading
ArcelorMittal's Commitment to Decarbonization ArcelorMittal is on a transformative journey to reshape its decarbonization strategy in Europe. The company has laid out a roadmap that prioritizes the replacement of traditional blast furnaces with lower carbon emissions facilities, specifically hydrogen-ready DRI-EAF systems. This endeavor marks a pivotal step forward in...
Continue Reading
Can International Stocks Surpass U.S. Performance? According to recent insights from a Vanguard economist, the landscape for stock investments is shifting, suggesting that international markets might finally outpace U.S. stocks. After facing challenges early in the year, U.S. stocks have rebounded impressively. The S&P 500 index has increased by approximately 16%...
Continue Reading
MellingMedical Receives Federal Supply Schedule Contract MellingMedical proudly announces its successful acquisition of a federal contract specifically designed for essential pharmaceuticals. This new agreement plays a pivotal role in ensuring America's veterans have timely access to critical medications and health products. Understanding the Federal Supply Schedule The...
Continue Reading
A Heavyweight Joins the Global Battery Materials Camp This isn't your run-of-the-mill executive shuffle, folks. Global Battery Materials Corp. (GBM) has just brought in a marksman in the battery world—Dr. Yi Hyon Paik. The guy doesn't just dabble; he's chalked up over 30 years in the trenches of battery technology, electronic materials, and the big leagues of energy...
Continue Reading
